Navigation Links
The 62nd Annual Meeting of the American Association for the Study of Liver Diseases
Date:9/15/2011

SAN FRANCISCO, Sept. 15, 2011 /PRNewswire/ -- The Liver Meeting® is the premier meeting in the science and practice of hepatology, including the latest findings on new drugs, novel treatments, and the results from pilot and multicenter studies.

Approximately 10 percent of Americans have some form of liver disease, but fortunately, the research community has made great strides in recent years in developing new treatments for patients.  

At this year's meeting, 2312 abstracts addressing these issues that will be presented, including 276 abstracts that will be presented in oral sessions. Those abstracts are available to members of the press at our website (www.aasld.org).

San Francisco, CA:  November 5 – 8, 2011

  • Poster Presentations:  November 5 – 8
  • Oral Presentations:  November 6 – 8  

An AASLD President's press conference highlighting key abstracts and issues presented at the Liver Meeting® is scheduled for Saturday, November 5 at 4:00 pm.

Two of this year's programs deal directly with the direct-acting antiviral agents that were recently approved by the FDA.  

  • The Hepatitis C Symposium is designed to educate the provider on newly approved and anticipated therapies for HCV and how these should be integrated into clinical practice.
  • The Hepatitis Debrief is designed to rapidly synthesize and summarize the new data presented at the Liver Meeting® in such a way that the information will be meaningful and useful.

Founded in 1950, AASLD is the leading organization of scientists and healthcare professionals committed to preventing and curing liver disease. AASLD has grown into an international society responsible for all aspects of hepatology, and our annual meeting attracts more than 8,000 physicians, surgeons, researchers, and allied health professionals from around the world.

Please contact AASLD at 703-299-9766 for information about the above presentations, or to receive any additional information about The Liver Meeting® – or visit our website at www.aasld.org.  

Please contact Gregory Bologna to register as press for the meeting: 703-299-9766 or gbologna@aasld.org.

Image to accompany this story: Liver meeting ad

http://www.xpresspress.com/images/liver-meeting.gif

This release was issued through The Xpress Press News Service, merging e-mail and satellite distribution technologies to reach business analysts and media outlets worldwide. For more information, visit http://www.XpressPress.com.


'/>"/>
SOURCE American Association for the Study of Liver Diseases (AASLD)
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Oramed Pharmaceuticals Chosen to Present at the 8th Annual Israel Strategic Partner and Venture Conference on September 22, 2011
2. Alexza Pharmaceuticals to Present at the Sixth Annual JMP Securities Healthcare Conference
3. Phreesia Unveils New Tool to Help Clinicians Document the Medicare Annual Wellness Visit
4. Intarcia Presents Compelling 48-week Results for ITCA 650 - Data Underlines the Promise to Become the First Injection-free GLP-1 Therapy at the 47th Annual EASD Meeting in Lisbon
5. Regado Biosciences to Present at the Annual UBS Global Life Sciences Conference in New York City
6. Delcath Systems, Inc. Hosts Symposium on Chemosaturation at CIRSE Annual Meeting
7. Savient Pharmaceuticals to Present at the Sixth Annual JMP Securities Healthcare Conference
8. Emergency Nurses Association Announces Corporate Sponsors for Annual Conference
9. Henry Schein to Present at the CL King 9th Annual Best Ideas Conference 2011
10. Positive Results From Avanafil Phase 3 Study in Diabetics Presented at the 47th EASD Annual Meeting
11. Lexicon Presents LX4211 Clinical Data at European Association for the Study of Diabetes Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2017)... HistoSonics, Inc., a venture-backed medical device company developing a non-invasive, robotically assisted, platform ... leadership team developments today:   ... ... Tom Tefft ... Veteran medical device executive Josh Stopek , PhD, who has led ...
(Date:9/12/2017)... and NEW YORK , Sept. 12, 2017 ... performance ratings for global supply chains, has published the first annual edition ... CSR performance of more than 20,400 companies evaluated by EcoVadis, based on ... 2015 and 2016. ... EcoVadis Global CSR Risk & Performance Index ...
(Date:9/9/2017)... , Sept. 9, 2017  Eli Lilly and ... primary and secondary endpoint data for lasmiditan, an investigational, ... which demonstrated statistically significant improvements compared to placebo in ... highlighted today at the 18th Congress of the International ... "The data presented today demonstrate lasmiditan,s potential ...
Breaking Medicine Technology:
(Date:9/21/2017)... , ... September 21, 2017 , ... ... learn with Infinity Behavioral Health Services for professionals in the addiction treatment industry ... Payer Audit . , Insurance companies and state and federal governments are ...
(Date:9/21/2017)... ... 2017 , ... Hair restoration surgery is having a moment, ... International Society of Hair Restoration Surgery (ISHRS). The worldwide volume of ... 635,189 procedures performed in 2016. , "Like other forms of cosmetic surgery ...
(Date:9/21/2017)... San Diego, Ca (PRWEB) , ... September 21, 2017 , ... ... and affordable services to its customers, and give back to the community. For over ... on of the most successful companies serving plumbing in San Diego. They ...
(Date:9/21/2017)... (PRWEB) , ... September 21, 2017 , ... ... using Microscan’s LVS 7510 at the Global GS1 Healthcare Conference 2017 in Chicago, ... the life-sciences industry for ensuring label quality and improving patient safety. , ...
(Date:9/21/2017)... ... September 21, 2017 , ... Preora Diagnostics Inc. , ... tests, has received two prestigious recognitions that acknowledge the promise of its PWS ... Preora has been named a Top 100 Finalist for the 16th annual Chicago ...
Breaking Medicine News(10 mins):